BERLIN, Aug. 11 (Xinhua) -- Revenues of German pharmaceutical company BioNTech in the second quarter (Q2) of 2020 reached 41.8 million euros (49.3 million U.S. dollars), compared with 25.8 million euros in Q2 last year, the firm announced on Tuesday.
Revenues from collaboration agreements went up as well because of new projects with U.S. company Pfizer and China's Fosun Pharma "as part of the company's BNT162 vaccine program against COVID-19," according to BioNTech.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!